Related Experiment Video
Updated: Jun 17, 2026
07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
[Retinal vasculitis in Crohn's disease: a case report]
S Trojet1, H Mazlout, M Hamdouni
1Service d'Ophtalmologie, Hôpital Habib Thameur, 8 Rue Ali Ben Ayed, 1008 Tunis, Tunisie. soniatrojet@yahoo.fr
Journal Francais D'Ophtalmologie
|December 22, 2009
Summary
Retinal vasculitis, a rare complication of Crohn's disease, can cause severe vision loss. Prompt corticosteroid treatment is crucial for managing this sight-threatening condition.
Area of Science:
- Ophthalmology
- Gastroenterology
- Internal Medicine
Background:
- Crohn's disease is a chronic inflammatory bowel disease with potential extra-intestinal manifestations.
- Posterior ocular complications of Crohn's disease are uncommon, with retinal vasculitis being exceptionally rare.
Observation:
- A 55-year-old male with a history of severe Crohn's disease presented with sudden vision loss in his only seeing eye.
- Examination revealed reduced visual acuity to light perception, retinal vasculitis involving veins, papillitis, and cystoid macular edema.
- Diagnostic imaging, including fluorescein angiography and OCT, confirmed the retinal vasculitis.
Findings:
- The patient was treated with high-dose corticosteroids (1mg/Kg/day) under close monitoring.
- A favorable clinical evolution was observed over a 9-month follow-up period, indicating treatment efficacy.
Implications:
- Retinal vasculitis in Crohn's disease represents a severe ocular complication with significant therapeutic and prognostic challenges.
- Early diagnosis and aggressive management, particularly in patients with monocular vision, are critical to prevent irreversible vision loss.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...